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https://doi.org/10.1016/j.celrep.2017.09.045SUMMARY
Arc is an activity-regulated neuronal protein, but
little is known about its interactions, assembly into
multiprotein complexes, and role in human disease
and cognition. We applied an integrated proteomic
and genetic strategy by targeting a tandem affinity
purification (TAP) tag and Venus fluorescent protein
into the endogenous Arc gene in mice. This allowed
biochemical and proteomic characterization of
native complexes in wild-type and knockout mice.
We identified many Arc-interacting proteins, of
which PSD95 was the most abundant. PSD95 was
essential for Arc assembly into 1.5-MDa complexes
and activity-dependent recruitment to excitatory
synapses. Integrating human genetic data with pro-
teomic data showed that Arc-PSD95 complexes
are enriched in schizophrenia, intellectual disability,
autism, and epilepsy mutations and normal variants
in intelligence. We propose that Arc-PSD95 post-
synaptic complexes potentially affect human cogni-
tive function.Cell
This is an open access article undINTRODUCTION
Arc/Arg3.1 was originally identified as a cytoskeletal-associ-
ated protein encoded by an mRNA that was rapidly transcribed
following synaptic activity and transported to dendrites (Link
et al., 1995; Lyford et al., 1995; Moga et al., 2004; Steward
et al., 1998). Many forms of neuronal activation induce Arc:
synaptic stimulation, including long-term potentiation (Guzow-
ski et al., 2000); metabotropic glutamate receptor-dependent
long-term depression (Jakkamsetti et al., 2013; Park et al.,
2008; Waung et al., 2008); homeostatic scaling of AMPA recep-
tors (Gao et al., 2010; Korb et al., 2013; Okuno et al., 2012;
Shepherd et al., 2006); generalized neuronal activity induced
by seizures (Link et al., 1995); as well as various behavioral
stimuli (memory- and experience-related behavioral patterns;
Daberkow et al., 2007; Gao et al., 2010; Guzowski et al.,
1999; Jakkamsetti et al., 2013; Kelly and Deadwyler, 2003;
Miyashita et al., 2009; Vazdarjanova and Guzowski, 2004; Vaz-
darjanova et al., 2006; Wibrand et al., 2012) and visual stimuli
(Wang et al., 2006). Knockout or knockdown of Arc results
in impaired synaptic plasticity and hippocampus-dependent
learning and behavior phenotypes reminiscent of schizophrenia
(Guzowski et al., 2000; Manago` et al., 2016; McCurry et al.,
2010; Plath et al., 2006; Wang et al., 2006).Reports 21, 679–691, October 17, 2017 ª 2017 The Author(s). 679
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Arc is mainly localized at postsynaptic sites of excitatory
synapses (Moga et al., 2004). The proteome of the postsynaptic
terminal of excitatory synapses of vertebrate species contains a
highly conserved set of1,000 protein types (Baye´s et al., 2011,
2012, 2017; Distler et al., 2014) organized into more than 200
multiprotein complexes (Frank and Grant, 2017; Frank et al.,
2016, 2017). The multiprotein complexes are organized into a
hierarchy of complexes and supercomplexes (complexes of
complexes), and the prototype supercomplex is formed by
PSD95 (Ferna´ndez et al., 2009; Frank et al., 2016, 2017; Husi
and Grant, 2001; Husi et al., 2000). Arc was found to be associ-
atedwith PSD95 (Ferna´ndez et al., 2009; Frank et al., 2016, 2017;
Husi et al., 2000), and genetic studies show that absence of
either PSD95 or Arc leads to enhanced long-term potentiation
(LTP) and impaired hippocampus-dependent learning (Migaud
et al., 1998; Plath et al., 2006). Biochemical purification
and mouse genetic experiments show that dimers of PSD95
assemble with multiple complexes, including NMDA receptors,
potassium channels, and signaling and adhesion proteins. These
are not all found within a single supercomplex but are within an
extended family of PSD95 supercomplexes ranging in size
from 1–3 MDa (Frank and Grant, 2017; Frank et al., 2016,
2017). A large-scale mouse genetic screen of more than 50
postsynaptic proteins found that PSD95 and its close interacting
proteins had the strongest phenotypes in synaptic electrophys-
iology and behavior, indicating that PSD95 supercomplexes are
crucial components of the postsynaptic terminal of excitatory
synapses (N.H.K., L.N. van de Lagemaat, L.E. Stanford, C.M.
Pettit, D.J. Strathdee, K.E. Strathdee, D.G.F., E.J. Tuck, K.A.E.,
T.J. Ryan, J.N., N.G. Skene, M.D.R.C., and S.G.N.G., unpub-
lished data; M.V.K., L.N. van de Lagemaat, N. Afinowi, D.J.
Strathdee, K.E. Strathdee, D.G.F., E.J. Tuck, K.A.E., N.G. Skene,
M.D.R.C., N.H.K., and S.G.N.G., unpublished data). Arc has also
been proposed to interact with the endocytic machinery (Dyna-
min and Endophilin-2 and -3) (Chowdhury et al., 2006; Rial Verde
et al., 2006; Shepherd et al., 2006). However, Arc multiprotein
complexes have not been purified and systematically studied
using proteomic mass spectrometry, and thus the identity of its
interacting partners and the composition of Arc complexes
remain poorly understood.
Characterizing protein complexes in synapses is technically
challenging. Gene-tagging of endogenous proteins in the mouse
has greatly facilitated purification of intact native complexes and
visualization of their subcellular localization and has many ad-
vantages over in vitro and recombinant methods (Broadhead
et al., 2016; Ferna´ndez et al., 2009; Frank andGrant, 2017; Frank
et al., 2016). The effect of mutations on complexes and neuronal
activation can be combined in mice carrying knockin gene tags,
and proteins that are predicted to be largely unstructured and
form multivalent interactions, such as Arc (Xue et al., 2010),
can be studied in their native context. These advantages have
been illustrated by the purification of native NMDA receptor
and PSD95 complexes, in which a tandem affinity purification
(TAP) tag was inserted into the N terminus of the GluN1 subunit
and C terminus of PSD95 by genome engineering (Ferna´ndez
et al., 2009; Frank et al., 2016). Purification revealed that
NMDA receptors and PSD95 were in 1.5-MDa supercom-
plexes with channel subunits, PSD95, and PSD93 asmajor com-680 Cell Reports 21, 679–691, October 17, 2017ponents. Genetic dissection in vivo using mutant mice showed
an essential tripartite requirement for PSD95, PSD93, and the
GluN2B cytoplasmic domain (Frank et al., 2016). This tripartite
interaction was not previously detected using in vitro methods,
which typically rely on binary protein interactions. Moreover,
like Arc, the GluN2B cytoplasmic domain is predicted to be a
structurally unfolded/disordered domain (Ryan et al., 2008),
and these domains lack stable tertiary structure and undergo
disorder-to-order transitions upon binding or changes in phos-
phorylation (Bah et al., 2015; Gibbs et al., 2017). We therefore
considered that Arc was well suited to the strategy of gene
tagging and genetic dissection.
Genetics has been a powerful approach for studying the
function of multiprotein complexes in many prokaryotic, eukary-
otic, and metazoan organisms, including humans, where
disease-causing mutations have been mapped to protein com-
plexes (Babu et al., 2014; Lu et al., 2013; Vidal et al., 2011). More-
over, in recent years, a large number of mutations that disrupt
postsynaptic proteins in humans have been identified and found
to cause many psychiatric, neurological, and developmental
disorders (Baye´s et al., 2011, 2014; Brose et al., 2010; Fromer
et al., 2014; Grant, 2012, 2013; Grant et al., 2005; Kirov et al.,
2012; Pocklington et al., 2006; Purcell et al., 2014). Although
mutations in the human ARC gene have not been directly linked
to any mental disorder, using preliminary proteomic data on
Arc-interacting proteins, the proteins in Arc complexes were
found to be enriched in disruptive mutations (Purcell et al.,
2014), de novo copy-number variants (CNVs) (Kirov et al.,
2012), non-synonymous de novo single-nucleotide variants
(SNVs), and small insertions or deletions (indels) (Fromer et al.,
2014) in schizophrenia cases. ARC protein has been described
to accumulate at synapses in Angelman syndrome (Greer
et al., 2010) and increased and/or decreased in several animal
models of Alzheimer’s disease and patient-derived cells (for a
review, see Kerrigan and Randall, 2013). These data suggest
that Arc is a component of protein complexes that are involved
with human cognitive disorders.
In this paper, we have conducted an extensive proteomic and
genetic dissection of Arc protein complexes, which is a generic
strategy suitable for the characterization of potentially any
synaptic protein. We have focused on the following four chal-
lenges: isolation of native multiprotein complexes from brain
tissue; visualization of the endogenous protein using genetic
tagging; genetic dissection of protein complex organization
and localization using mouse genetic models; and genetic
dissection of complexes using human genetic data, including
human disease and cognitive phenotypes. Here we demonstrate
that this integrated proteomic and genetic strategy reveals in-
sights into the physiological functions of Arc and the synaptic
basis of mental disorders and intelligence.
RESULTS
TAP Tagging and Proteomic Analysis of Endogenous Arc
Complexes
To label and isolate endogenous Arc protein, we engineered
knockin mice (ArcTAP) harboring a TAP tag fused to the C termi-
nus of Arc (Figures 1A–1D). Mice carrying the TAP tag showed no
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Figure 1. Generation of TAP-Tagged Arc Knockin Mice
(A) Scheme of the genomic Arc locus targeted with the TAP tag. The TAP sequence was inserted before the stop codon of the protein. The cross of ArcTAP knockin
mice with a transgenic Cre-expressing mouse line deleted the neomycin (neo) resistance cassette by recombination between loxP sites. Asterisk, stop codon
(TAA) of the coding sequence; thick black line, TAP tag sequence; triangle, loxP site.
(B) Structure of the TAP-tagged Arc regions, including a potential coiled-coil domain, an SH3-endophilin-2 and -3 binding region, a dynamin-2 binding region, and
the C-terminal TAP tag sequence domain before the stop codon of the protein.
(C) PCR amplification of WT (bottom band) and TAP Arc-targeted alleles (top band).
(D) TAP-tagged Arc was specifically purified from ArcTAP/+ forebrain extracts with anti-Arc and anti-FLAG antibodies and blotted with an anti-Arc antibody.
(E) Hippocampal sections of WT and ArcTAP/TAP mice stained with an anti-Arc antibody. DG, dentate gyrus. Scale bar, 1 mm. Shown is a representative image of
n = 2 mice for each genotype.
(F) Representative image of embryonic primary neurons derived fromWT and ArcTAP/TAP mouse independent cultures immunostained at day in vitro (DIV) 15 with
antibodies against Arc (green), PSD-95 (red), and Synaptophysin (blue). Merged, colocalization of the three signals. Arrows show the punctum labeling for each
protein. Scale bar, 10 mm.
(G) Biochemical fractionation from ArcTAP/TAP and WT mouse forebrains. Similar protein amounts from each fraction were loaded onto a gel and immunoblotted
with the antibodies displayed at the right. TAP-tagged Arc showed the same subcellular distribution as theWT non-tagged isoform. The fractions are described in
the Supplemental Experimental Procedures. Antibodies against synaptophysin were used as a specific marker of the SN3 fraction. Actin was used as a loading
control. MW, molecular weight in kilodaltons; TAP/+, heterozygous for TAP-tagged Arc; c-, PCR water; IgG, mouse total immunoglobulin G.
(legend continued on next page)
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Figure 2. TAP of Arc Reveals Postsynaptic
Complexes with a Native Size of 1.5 MDa
(A) BNP of WT and ArcTAP/+ forebrain extracts
blotted with FLAG and Arc antibodies, where Arc
and TAP-tagged Arc can bemainly detected at 1.5
MDa. The closed arrow indicates the main Arc
complex, whereas open arrows indicate lower-
molecular-weight Arc complexes.
(B) Arc was tandem affinity-purified from
ArcTAP/TAP forebrain extracts, eluted, and
collected in 5 consecutive fractions following his-
tidines affinity tag (HAT) purification.
(C) Colloidal Coomassie staining of three inde-
pendent TAPs from WT (left) and ArcTAP/TAP (right)
forebrains. The lanes were cut for LC-MS/MS, and
the identified proteins are listed in Table S1. Arc
and the Tev enzyme are indicated.
(D) The absolute expression value of each protein
in the tandem purification was estimated by the
iBAQ intensity values obtained in each purification.
(E) BNP of WT, ArcTAP/+, and PSD95TAP/+ forebrain
extracts blotted with FLAG antibody. TAP-tagged
Arc and TAP-tagged PSD95 levels are detected.
TAP/+, heterozygous for TAP-tagged Arc or
PSD95 as indicated; SN, supernatant.detectable alterations in the levels or localization of Arc in the
brain or in hippocampal synaptic physiology (Figures 1E–1J).
Native Arc complexes were detected by immunoblotting of brain
extracts separated on blue native PAGE (BNP), which showed a
major band of a median mass of 1.5 MDa, with several addi-
tional minor species ranging from 200–700 kDa (Figure 2A).
The TAP tag was used to isolate Arc complexes directly from
mouse forebrain tissue using a highly efficient purification
protocol (recovering >70% Arc) (Figures 2B and 2C), and
their composition was determined using liquid chromatog-
raphy-tandem mass spectrometry (LC-MS/MS). The single-
step purification yielded 107 high-confidence proteins, whereas
the more stringent tandem purification protocol recovered a
subset of 39 proteins (34 of 39 were uncovered by single-step
purification) (Experimental Procedures; Table S1; http://www.
genes2cognition.org/publications/tap-arc). Eight of 14 previ-
ously reported Arc interactors were found among the 107
high-confidence proteins, indicating that 99 were novel interac-
tors (Supplemental Experimental Procedures). Among the 107(H) Basal synaptic transmission was normal in ArcTAP/TAPmice. Areas under input-output curves were not stati
animals (n = 18, N = 5) (F(1,7.06) = 0.258; p = 0.627).
(I) Normalized magnitude of the LTP 60–65 min after LTP induction did not differ in mutant mice (166% ± 5%;
their WT counterparts (171% ± 4%; n = 18, N = 5).
(J) Paired-pulse facilitation was not statistically different (F(1,7.36) = 2.405; p = 0.163) in Arc
TAP/TAP animals (n = 1
N = 5).
Data are presented as mean ± SEM, with n = slices and N = mice.
682 Cell Reports 21, 679–691, October 17, 2017high-confidence proteins, 72 proteins
contain the Arc-N lobe consensus motif
P[STVILMKR][FYH] (Zhang et al., 2015),
revealing a strong network of direct inter-
actors (Table S1). Comparisons of mouseand human show that 87% (92 of 107) of Arc-interacting proteins
were conserved between species (Table S2), 70% (1,012 in hu-
man and 1,447 in mice) of protein-protein interactions were
conserved (Table S3), and the Arc interactome was enriched
(72%) in proteins in the human postsynaptic complexes found
by Baye´s et al. (2012) (Table S3). Together, these results suggest
that we have defined a robust Arc complex and interactome that
is highly conserved between mouse and human.
PSD95 was the most abundant Arc-interacting protein. Using
intensity-based absolute quantification (iBAQ) quantification
(Schwanha¨usser et al., 2011) of the single-step purification, it
showed 1:1 stoichiometry with Arc (Figure 2D; Table S4), and
in the tandem-purification, it represented 57% of the Arc interac-
tome (Table S4). Reciprocal immunoprecipitations show that
PSD95 assembles into Arc complexes from early developmental
stages (post-natal day 11 [P11]) in the hippocampus and cortex
(Figures S1A and S1B). The Dlg family of adaptor/scaffold
proteins, comprising four paralogs (SAP97/Dlg1, PSD93/Dlg2,
SAP102/Dlg3, and PSD95/Dlg4), was the most abundant ofstically different in ArcTAP/TAP (n = 15, N = 5) andWT
n = 15, N = 5; F(1,7.75) = 0.449; p = 0.522) relative to
5, N = 5) comparedwith theirWT littermates (n = 18,
A B
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Figure 3. Arc Protein Levels Are Reduced in
Fractions of PSD95 Knockout Mice
(A) Representative immunoblot showing the rela-
tive abundance of PSD95, Arc, GluR1, and GluR2
proteins in total hippocampal lysates from
PSD95/ and matched WT littermates. Arc is
reduced to 35.0% ± 17.1% of theWT in the PSD95
mutant mice (N = 4 for each matched pair, *p <
0.05). Neuronal NOS (nNOS) was used as a
loading control.
(B) Representative Arc staining of sagittal sections
of the hippocampus (left) and magnification of the
granular layer (right) for WT and PSD95 knockout
mice. Scale bar, 1 mm.
(C) Hippocampal extracts of PSD95 mutant and
WT mutant mice were biochemically fractionated
into synaptosomes and into cytoskeletal and
vesicular components, referred to as ‘‘light.’’ The
synaptosomal fraction was subsequently dissoci-
ated into PSDs and Triton X-100 soluble fraction.
Arc levels were dramatically reduced in the PSD95
mutant, whereas no changes in GluR1, GluN2B,
IRSp53, and Rac1 proteins were observed.
(D) Blue native PAGE (BNP) of WT and PSD95
knockout forebrain extracts blotted with Arc and
PSD95 antibodies. Long exposure of the blots
shows Arc complexes migrating at a lower mo-
lecular weight than 1.20 MDa (center). SN, Triton
X-100 soluble fraction.eleven protein classes recovered, suggesting that they play a
principal role in regulating Arc function (Figure S1C; Tables S5
and S6). Specificity of interaction between Arc and Dlg paralogs
was suggested by the finding that PSD93 and SAP97 were also
highly abundant, whereas SAP102 was not detected in the Arc
interactome (confirmed using reciprocal immunoprecipitation;
Figure S1D). Forty-nine percent of Arc-interacting proteins
were known PSD95 interactors and particularly enriched in
membrane proteins, including NMDA and AMPA receptors
(Table S1).
Consistent with their co-assembly with Arc, the NMDA recep-
tor, PSD95, and PSD93 were also shown to reside in 1.5-MDa
supercomplexes (Frank et al., 2016). To compare the relative
abundance of Arc and PSD95 in 1.5-MDa supercomplexes, we
immunoblotted ArcTAP/+ and PSD95TAP/+ brain extracts sepa-
rated by BNP with FLAG antibodies (Figure 2E). PSD95 was
20-fold more abundant than Arc, indicating that 5% of
PSD95 complexes contain Arc. Pull-down of PSD95 complexes
using the TAP tag recovered 65% of PSD95 and depleted 37%
of Arc, indicating that 58% of Arc is in PSD95 supercomplexes
(data not shown). Together, these data indicate that PSD95 is the
major interacting protein of Arc and that a subset of the postsyn-
aptic 1.5-MDa PSD95 supercomplexes contain Arc.
Arc Postsynaptic Localization Requires PSD95
How Arc is localized to the postsynaptic terminal is unknown. To
address this question, we asked whether members of the Dlg
scaffold protein family were required in vivo, using mice carrying
knockout mutations in PSD95, PSD93, and SAP102 (SAP97
knockout mice are nonviable). In hippocampal extracts, we
found that Arc protein levels were reduced (35.0% ± 17.1% ofthe wild-type [WT], p < 0.01) in PSD95 knockout mice but not
in PSD93 or SAP102 knockout mice (Figure 3A; Figures S1E
and S1F). A dramatic loss of dendritic staining of Arc was
observed in hippocampal sections from PSD95 knockout mice
(Figure 3B). Furthermore, synaptosomes from PSD95 knockout
mice also showed a major reduction in Arc (Figure 3C). We
also examined BNP immunoblots from PSD95 knockouts and
found that 1.5-MDa Arc complexes were severely diminished,
with a weak residual signal after long exposure of the gel (Fig-
ure 3D). Thus, PSD95 is specifically required to localize Arc to
the postsynaptic terminal.
To visualize endogenous Arc protein, we created ArcVenus
knockin mice using a similar design strategy as for the ArcTAP
mice, where the Venus fluorescent protein was fused to the C
terminus of Arc (Figures 4A–4C). Mice carrying the Venus
tag showed no detectable alterations in hippocampal synaptic
physiology (Figures 4D–4F). We bred Arc-Venus mice
with PSD95 knockouts to generate compound transgenic
mice (ArcVenusxPSD95/) and asked whether kainic acid-
induced neuronal activity (Li et al., 2005) would drive Arc to
the synapse and whether this required PSD95. In the absence
of PSD95, Arc-Venus failed to localize to the synapse (Fig-
ure 4G). These results demonstrate that PSD95 is required
for the postsynaptic localization of Arc into 1.5-MDa com-
plexes in the steady state and following induction by neuronal
activity.
Proteomic Analysis of Arc Complexes in Mice Lacking
PSD95
We reasoned that, by genetic removal of PSD95, we could
identify those Arc-interacting proteins that weremost dependentCell Reports 21, 679–691, October 17, 2017 683
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Figure 4. Generation of Venus-Tagged Arc Knockin Mice
(A) The Venus sequence was inserted before the stop codon of the protein using the TAP vector as template. The cross of both knockin mice with a transgenic
Cre-expressing mouse line deleted the neo resistance cassette by recombination between loxP-sites. Asterisk, stop codon (TAA) of the coding sequence; thick
black line, TAP and Venus tag sequence, as indicated; triangle, loxP site.
(B) Structure of the Venus-tagged Arc regions as in Figure 1B.
(C) PCR amplification of WT (bottom band) and Arc Venus-targeted alleles (top band). Venus/+, heterozygous for Venus-tagged Arc.
(D) Input-output relationships illustrate averaged field excitatory postsynaptic potential (fEPSP) amplitudes in slices from ArcVenus/Venus (n = 26, N = 8) and
WT mice (n = 22, N = 8) in response to stimulation of Schaffer collaterals. Areas under input-output curves were not significantly different between genotypes
(F(1,13.06) = 0.499; p = 0.493).
(E) Normalized magnitude of LTP 60–65 min after LTP induction did not differ significantly in mutant mice (185% ± 4%; n = 25, N = 8; F(1,11.64) = 2.92; p = 0.114)
relatively to their WT counterparts (174% ± 4%; n = 22, N = 8).
(F) Paired-pulse facilitation was not statistically different (F(1,11.08) = 1.372, p = 0.266) in Arc
Venus/Venus animals (n = 26, N = 8) compared with their WT littermates
(n = 22, N = 8). Data are presented as mean ± SEM, with n = slices and N = mice.
(G) Representative section of ArcVenus mouse brain crossed with WT (left) and PSD95/ (right) mice. Shown is a bar chart of the total cell fluorescence corrected
by the area and the background signal. Scale bars, 15 mm.on PSD95. We bred ArcTAP/TAP with PSD95 knockout mice
(ArcTAP/TAP/PSD95/) and analyzed their Arc interactome using
quantitative proteomic methods (Figures 5A–5C; Table S7). As
shown in Figure 5C, Arc-interacting proteins separated into
two broad subgroups: depleted and enriched proteins (see red
and green proteins, respectively). Seventy percent of depleted684 Cell Reports 21, 679–691, October 17, 2017proteins were PSD95-interacting proteins, including PSD93. As
shown by immunoblots of BNPs, PSD93 remained in 1.5-MDa
complexes in PSD95/ mice (Figure 3D; Frank et al., 2016).
Absence of PSD93 did not affect the interaction of Arc with
PSD95 (Figure S1G). The most significant gene ontology
(GO) biological process (BP) terms in the depleted proteome
AC
B
D
Figure 5. Quantitative Proteomics Analysis of ArcTAP Reveals a Depletion of Postsynaptic Proteins in PSD95 Knockout Mice
(A) Arc complexes were isolated from ArcTAP/+ and ArcTAP/TAP mice crossed with PSD95 knockout mice (ArcTAP/TAPxPSD95/) by FLAG capture and Tev
protease release (single-step purification). Total lysate (IN, input) and the same volume of lysate upon purification (SN) and Tev elution from both genotypes were
blotted against Arc and quantified. Eluted Arc levels following the FLAG capture from ArcTAP/+ and ArcTAP/TAPxPSD95/ lysates were not statistically different
(Mann-Whitney U test, p = 0.1). Data are presented as mean ± SEM.
(B) Isolated complexes from (A) were resolved by SDS-PAGE and stained with colloidal Coomassie. Three independent purifications are shown. The lanes were
cut for LC-MS/MS analysis, and the identified proteins are listed in Table S7. TAP-tagged Arc, PSD95, and the Tev enzyme are indicated.
(C) Dimethyl labeling-based quantitative MS of TAP-purified proteins from ArcTAP/+ and ArcTAP/TAP crossed with PSD95 knockout mouse forebrain
(ArcTAP/TAP3PSD95/). The plot displays enrichment ratios of ArcTAP/TAP3PSD95/ versus ArcTAP/+ (x axis) and iBAQ enrichment values of the step purification
(y axis). Proteins meeting criteria for enrichment (>1.5 fold) are highlighted in green and for depletion (< 0.667 fold) are highlighted in red. The names of depleted
and enriched PSD95 interactors are indicated. See the Supplemental Experimental Procedures for enrichment criteria.
(D) Mouse interactome network constructed from the publicly available databases BioGrid, Database of Interacting Proteins (DIP), IntAct, Molecular INTeraction
Database (MINT), STRING database, UniProt, Biomolecular Interaction Network Database (BIND) andmentha using the Psicquic software package. The network
is visualized using Visone. Proteins highlighted in green/red meet the enrichment/depletion criteria discussed in the Supplemental Experimental Procedures.were synaptic transmission (p = 1.233 1011), cell-cell signaling
(p = 3.94 3 109), and modulation of synaptic transmission (p =
1.35 3 107), highlighting the functional importance of the
depleted proteins (Table S6).
Among the 12 most enriched proteins in the Arc complexes
isolated from PSD95 mutant mice were SAP97 and structural
proteins, including those with a potential role in cell growth and
adhesion (Claudin11 and Lgi1). A network graph of the interac-
tions of the enriched and depleted protein sets is shown in
Figure 5D. The internal network consists of 26 proteins and 44 in-
teractions (visualized using Visone; Brandes and Wagner, 2012).
Taken together, these proteomic and in vivo genetic studies
show that Arc is tethered to postsynaptic 1.5-MDa signalingcomplexes containing PSD95, and when these complexes are
abolished in PSD95 mutants, Arc is found associated with cyto-
skeletal and structurally related proteins. Thus, Arc is partitioned
into either the PSD95 supercomplexes in the postsynaptic termi-
nal or into cytoskeletal complexes.
Arc Complexes in Disease
Proteins within the postsynaptic proteome are assembled into
complexes and supercomplexes (Frank et al., 2016), and this su-
pramolecular organization is of crucial importance in human
genetic disorders because it is a mechanism by which the
many different gene products functionally converge. We there-
fore combined our proteomic datasets with human geneticCell Reports 21, 679–691, October 17, 2017 685
datasets to understand the importance of Arc-interacting pro-
teins in human disease.
Preliminary proteomic data from ArcTAP mice was previously
used to implicate the disruption of ARC complexes in human
psychiatric disorders (Fromer et al., 2014; Kirov et al., 2012;
Purcell et al., 2014). The first such study revealed that compo-
nents of Arc complexes were enriched in de novo CNVs from
individuals with schizophrenia (Kirov et al., 2012), with subse-
quent studies finding enrichment for rare point mutations in
individuals with schizophrenia, autism, and intellectual disability
(ID). Here we extend preliminary proteomic data from ArcTAP
mice using complete sets of Arc-interacting proteins and addi-
tional genetic datasets, including epilepsy and healthy control
de novo datasets.
Wefirst sought to replicate the initial findingofKirov et al. (2012)
with the comprehensive Arc interactome. Utilizing the same ge-
netic dataset as Kirov et al. (2012), we found that de novo CNVs
from schizophrenia probands were enriched for Arc complex
genes compared with de novo CNVs from unaffected individuals
(p = 0.0047). Arc interactors whose association with Arc is
depleted in PSD95 knockout mice largely drove this enrichment
(p = 0.0165), indicating the importance of the postsynaptic
1.5-MDa complexes. We next investigated enrichment of the
Arc interactome for rare point mutations and indels contributing
to brain disorders, using exome sequencing data from a case/
control schizophrenia study (Purcell et al., 2014) and de novo
studies performed in cohorts of schizophrenia, autism, ID, and
epilepsy (Supplemental Experimental Procedures). Combining
evidence from each of these independent datasets, we found
strong support for the enrichment of both nonsynonymous (NS)
and loss-of-function (LoF) disease-related mutations among
Arc interactors (p = 9.013 1012 and 2.0513 107, respectively;
Table 1). All five datasets contributed to this enrichment (Table 1;
Tables S8 and S9), indicating that disruption of Arc complexes
may contribute to a wide range of brain disorders. Consistent
with the analysis of de novo CNVs, much of the enrichment in
LoF and NS mutations was attributable to Arc interactors whose
expression is altered in the PSD95/ mouse. This suggests
that it is postsynaptic Arc-PSD95 complexes and not cyto-
plasmic Arc complexes that are relevant to these disorders.
Arc Complexes in Normal Variation in Human
Intelligence
Although the role in cognition for Arc, PSD95, and their interacting
proteins is well established from studies of mutations in mice
(Ferna´ndez et al., 2009; Fitzgerald et al., 2014; Husi et al., 2000;
Komiyama et al., 2002; McCurry et al., 2010; Migaud et al.,
1998; Nithianantharajah et al., 2013; Plath et al., 2006; Ryan
et al., 2013), mutations in humans cause cognitive disorders,
and enrichment analysis of Arc-interacting proteins for mamma-
lian phenotype (MP) terms shows 48 enriched terms (p < 0.01)
associated with abnormal synaptic and cognitive functions
(Table S10), much less is known about the relevance to normal
variation in human cognition. We therefore asked whether com-
mongenetic variation inArc complexeswasassociatedwith com-
mon variation in general cognitive ability (known as intelligence
or g) using the genome-wide association study (GWAS) on intelli-
gence from the five cohorts (n = 3,511) thatmake up theCognitive686 Cell Reports 21, 679–691, October 17, 2017Aging inEnglandandScotland (CAGES) consortium (Davies et al.,
2011;Hill et al., 2014). Thefivecohorts are theLothianBirthCohort
of 1921and1936 (Deary et al., 2012), theAberdeenBirthCohort of
1936 (Whalley et al., 2011), and the Manchester and Newcastle
Longitudinal Studies of Cognitive Aging (Rabbitt et al., 2004),
which together consist of a total of 3,511 healthy middle- to old-
aged individuals who all live independently in the community.
The measure of general cognitive ability was taken from the
GWAS previously conducted by Hill et al. (2014) (Supplemental
Experimental Procedures). To determine whether there was a
greater weight of evidence for association between the Arc gene
set and general cognitive ability, a two-stage enrichment test
was used. First, SNPs were assigned to autosomal genes, and a
gene based statistic was derived (Liu et al., 2010). Second, the
p values of the gene-based statistics were –log(10)-transformed
before gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) and a competitive test of enrichment, was used.
The results of the gene-based analysis are shown in Table S11,
where eight genes were nominally significant in CAGES and nine
in the Brisbane Adolescent Twin Study (BATS). The most signifi-
cant gene in theBATScohort (PRRT1, p=0.00732)wasalsonomi-
nally significant in CAGES (p = 0.03797). The results of the enrich-
ment analysis show that commongenetic variation inArc complex
proteins shows nominally significant association (p = 0.0473) with
intelligence compared with control gene sets. A replication study
using the summarydata of aGWASconductedon intelligence (Hill
et al., 2014), theBATS (n = 2,062; de Zubicaray et al., 2008;Wright
et al., 2001; Wright and Martin, 2004), also showed a significant
enrichment (p = 0.0247), confirming the results found in the
CAGES consortium. This significant enrichment shows that com-
mongenetic variation in the genesencodingArccomplexproteins
is associated with the normal variation in human intelligence
differences.
DISCUSSION
We have developed and demonstrated an integrated proteomic
and genetic strategy that reveals insights into Arc’s role in
biology, the synaptic basis of mental disorders, and intelligence.
Multiple genetic and genome engineering methods were com-
bined to isolate native Arc complexes, identify their constituents,
determine the mechanism of assembly and localization to
the postsynaptic terminal, and identify multiple diseases and
mutations that converge on the complexes.
The Arc protein is principally housed within 1.5-MDa com-
plexes, and proteomic MS identified many novel Arc-interacting
proteins, of which PSD95 was the most abundant. PSD95 and
Arc coassemble into 1.5-MDa supercomplexes, and knockout of
PSD95 abolishes these complexes, severely depletes Arc from
the postsynaptic terminal, and prevents its activity-dependent
recruitment. The combined use of gene-tagged and mutant mice
allowed us to dissect the interactions of Arc with specific subsets
of postsynaptic complexes. PSD95 supercomplexes are a family
of which 3% contain NMDA receptors (Frank et al., 2017). The
NMDA receptor requires PSD93 for coassembly with PSD95
(Frank et al., 2016), and in the present study, we found that
PSD93 knockouts did not interfere with Arc-PSD95 interactions.
Therefore, Arc can assemble with PSD95 supercomplexes that
Table 1. Arc Gene Set Analysis of Autism, Schizophrenia, Epilepsy, ID, and Schizophrenia Candidate Gene Sets
All Arc Interactors
Arc Interactors with
Increased Expression
in PSD95/Dlg4/ Mice
Arc Interactors with
Decreased Expression
in PSD95/Dlg4/ Mice
Arc Interactors that Are
Known Direct PSD95-
Interacting Proteins
N = 107 N = 11 N = 24 N = 18
Mutation Class Disease Study Design P O/E P O/E P O/E P O/E
CNVs schizophrenia de novo 0.00469 – 0.50211 – 0.01648 – 0.01648 –
LoF combined – 2.05E-07 – 1.00000 – 1.57E06 – 3.03E06 –
autism de novo 0.14352 11/4.0 1.00000 0/0.4 0.10920 6/1.2 0.00104 8/0.8
epilepsy de novo 0.39935 3/0.4 1.00000 0/0 1.00000 1/0.1 1.00000 0/0.1
ID de novo 0.00104 8/0.5 1.00000 0/0 0.00104 5/0.1 0.00936 3/0.1
schizophrenia de novo 1.00000 3/0.8 1.00000 1/0.1 1.00000 2/0.2 0.60527 2/0.2
schizophrenia case/control 1.00000 56/38 1.00000 12/9 1.00000 15/9 1.00000 6/6
NS combined – 9.01E12 – 1.00000 – 1.59E06 – 1.26E08 –
autism de novo 0.01352 46/25.9 1.00000 2/2.5 1.00000 15/8.5 0.00416 18/5.8
epilepsy de novo 0.00104 16/2.5 1.00000 0/0.3 1.00000 3/0.8 1.00000 2/0.6
ID de novo 0.00104 15/2.0 1.00000 0/0.2 0.00104 8/0.6 0.00104 8/0.4
schizophrenia de novo 0.11856 14/5.7 1.00000 3/0.6 0.58759 6/1.8 0.47839 5/1.3
schizophrenia case/control 1.00000 187/184 1.00000 22/21 1.00000 61/48 0.72800 40/31
Shown are enrichment test empirical p values for autism (De Rubeis et al., 2014; Iossifov et al., 2012; Jiang et al., 2013), epilepsy (EuroEPINOMICS-RES Consortium et al., 2014), ID (de Ligt et al.,
2012; Hamdan et al., 2014; Rauch et al., 2012), and schizophrenia (Fromer et al., 2014; Girard et al., 2011; Gulsuner et al., 2013; Kirov et al., 2012; McCarthy et al., 2014; Xu et al., 2012). For de
novo studies, O/E indicates the observed versus expected (under a null model) number of mutations in that class. For the schizophrenia (SCZ) case/control study, O/E indicates the number of
case versus control mutations. P indicates Bonferroni multiple-test correction: four tests for CNVs, 12 tests for Lof/NS combined analyses, and 52 tests for LoF/NS in individual studies. Fisher’s
method was used to combine p values from the five independent genetic datasets (‘‘combined’’ p value for LoF and NS mutations). PSD95/, PSD95/Dlg4 knockout mice.
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do not contain NMDA receptors. We also found that Arc did
not interact with SAP102, which forms distinct complexes at
350 kDa (Frank et al., 2016), nor did Arc require SAP102 for post-
synaptic targeting. Together, these results demonstrate that Arc is
targeted to the postsynaptic terminal, where it selectively interacts
with signaling complexes organized by PSD95. Super-resolution
microscopy has revealed that PSD95 and SAP102 are in separate
nanodomains (Zheng et al., 2011) within the dendritic spine and
that PSD95 nanodomains (Broadhead et al., 2016; Fukata et al.,
2013; Nair et al., 2013) are positioned beneath the presynaptic
release machinery (Tang et al., 2016). This suggests that Arc is
selectively targetedbyPSD95 to this critical regionof the postsyn-
aptic terminal, where its supercomplexes participate in controlling
synaptic transmission and plasticity.
Disruption of many proteins in Arc-PSD95 complexes, and
many other proteins in the supercomplexes leads to changes in
synaptic plasticity and behavior, including knockout of Arc and
PSD95, which both lead to enhanced LTP and impaired learning
(Carlisle et al., 2008; Migaud et al., 1998; Nithianantharajah et al.,
2013; Plath et al., 2006; N.H.K., L.N. van de Lagemaat, L.E. Stan-
ford, C.M. Pettit, D.J. Strathdee, K.E. Strathdee, D.G.F.,
E.J. Tuck, K.A.E., T.J. Ryan, J.N., N.G. Skene, M.D.R.C., and
S.G.N.G., unpublished data; M.V.K., L.N. van de Lagemaat,
N. Afinowi, D.J. Strathdee, K.E. Strathdee, D.G.F., E.J. Tuck,
K.A.E., N.G. Skene, M.D.R.C., N.H.K., and S.G.N.G., unpub-
lished data). A recent large-scale genetic screen of postsynaptic
proteins in mice showed that PSD95 supercomplexes were
essential for the postsynaptic responses to simple and complex
patterns of activity and themodulation of synaptic strength over a
range of milliseconds to an hour (M.V.K., L.N. van de Lagemaat,
N. Afinowi, D.J. Strathdee, K.E. Strathdee, D.G.F., E.J. Tuck,
K.A.E., N.G. Skene, M.D.R.C., N.H.K., and S.G.N.G., unpub-
lished data). The supercomplexes were also essential for tuning
the magnitude of innate and learned behavioral responses,
including simple and complex forms of behavior (N.H.K., L.N.
van de Lagemaat, L.E. Stanford, C.M. Pettit, D.J. Strathdee,
K.E. Strathdee, D.G.F., E.J. Tuck, K.A.E., T.J. Ryan, J.N., N.G.
Skene,M.D.R.C., andS.G.N.G., unpublisheddata). Furthermore,
these studies show that each innate and learned behavioral
response required a specific subset or combination of postsyn-
aptic proteins, which suggests that transient upregulation and
targeting of Arc to PSD95 supercomplexeswill transientlymodify
behavior and synaptic physiology. This mechanism is consistent
with the known role of Arc in learning.
The proteomes of the post-synaptic density (PSD) and PSD95
supercomplexes are highly conserved betweenmice and humans
(Baye´s et al., 2011), and specific genes (e.g., PSD93) have
conserved roles in cognition (visuo-spatial learning, cognitive flex-
ibility, and attention) (Nithianantharajah et al., 2013). Our finding
that human genetic disorders of cognition converge on Arc-
PSD95 supercomplexes is in agreement with the mouse genetic
findings. Here we have reaffirmed the role of the supercomplexes
in schizophrenia and extended the study to autism and ID.
Moreover, the finding that variation in normal human intelligence
and disorders of cognition involves the same sets of proteins
indicates that genetic variation inArc-PSD95 supercomplexesun-
derpins the phenotypic continuumbetween normal cognitive vari-
ation and pathology.688 Cell Reports 21, 679–691, October 17, 2017There are over 130 brain diseases linked to mutations in the
postsynaptic proteome (Baye´s et al., 2011) and a large number
of uncharacterized multiprotein complexes (Frank et al., 2016),
many of which contain at least one protein encoded by a
disease gene. The integrated workflow shown here, which
is centered on genetically tagged mice and proteomic ap-
proaches, offers a general and scalable approach toward un-
derstanding how the polygenic basis of brain disease is linked
to the supramolecular organization of proteins in the postsyn-
aptic terminal of central synapses. All datasets are freely
available through the Genes to Cognition website (http://
www.genes2cognition.org).
EXPERIMENTAL PROCEDURES
Animals
All animal experiments were conducted in a licensed animal facility in accor-
dance to guidelines determined by the UK Animals (Scientific Procedures)
Act, 1986 and approved through the U.K. Home Office Inspectorate. Animal
care at KU Leuven was conducted according to national and international
guidelines and as described in the Supplemental Experimental Procedures.
All mice were 2- to 5-month-old males unless indicated otherwise.
TAP
TAPwas performed as by Ferna´ndez et al. (2009). Briefly, mouse forebrain was
homogenized on ice in 1%deoxycholate (DOC) buffer (50mMTris [pH 9.0], 1%
sodium deoxycholate, 50 mM NaF, 20 mM ZnCl2, and 1 mM Na3VO4), 2 mM
Pefabloc SC (Roche), and 1 tablet/10 mL protease inhibitor cocktail tablets
(Roche) at 0.38 g wet weight per 7 mL cold buffer with a glass Teflon Douncer
homogenizer. The homogenate was incubated for 1 hr at 4C and clarified at
50,000 3 g for 30 min at 4C. TAP-tagged complexes were isolated as
described previously (Ferna´ndez et al., 2009). The SDS-PAGE gel was fixed
and stained with colloidal Coomassie, and lanes were cut into slices, de-
stained, and digested overnight with trypsin (Roche, trypsin modified,
sequencing grade) as described previously (Ferna´ndez et al., 2009). Peptide
digestion, LC-MS/MS, and proteomics data analysis are described in the Sup-
plemental Experimental Procedures.
Enrichment Analysis of CNVs and Rare Coding Mutations in Arc
Interactors in Human Neuropsychiatric Disease
The protein IDs from Table S1 were converted into both mouse genome infor-
matics (MGI) and mouse NCBI/Entrez gene IDs using the online ID mapping
tool provided by Uniprot and then converted to human Entrez IDs using the
mapping file ‘‘HOM_MouseHumanSequence.rpt,’’ available from MGI (http://
www.informatics.jax.org/). Any genes with a non-unique (e.g., 1-many) map-
ping between species, or where MGI and mouse Entrez IDs mapped to
different human genes, were excluded. De novo CNV enrichment analysis
and de novo mutation exome sequencing datasets are detailed in the Supple-
mental Experimental Procedures.
Human Cognitive Ability Phenotype and Analysis
The phenotypes used in both the CAGES and the BATS samples were taken
from the summary data of Hill et al. (2014) and are described in the Supple-
mental Experimental Procedures. Genome-wide association had been carried
out in each cohort of CAGES using Mach2QTL (Li et al., 2010) before being
meta-analyzed in METAL (Willer et al., 2010) and is detailed in the Supple-
mental Experimental Procedures.
All other methods are described in the Supplemental Experimental
Procedures.
DATA AND SOFTWARE AVAILABILITY
The accession number for the mass spectrometry proteomics data reported in
this paper is ProteomeXchange Consortium: PXD007283.
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